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ucing a vaccine to immunise those at high risk but more strains
eed to be serotyped to decide on the vaccine.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.838
ype: Poster Presentation
inal Abstract Number: 45.048
ession: Bacterial Infections
ate: Friday, June 15, 2012
ime: 12:45-14:15
oom: Poster & Exhibition Area
CCmec type IX in a community-acquired methicillin-resistant
taphylococcus aureus isolate: ﬁrst report in a patient from
hailand
. Lulitanond1,∗, T. Ito2, S.S. Li 2, X. Han2, X.X. Ma2, C. Engchanil3,
. Jiwakanon4, A. Chanawong1, C. Wilailuckana1, K. Hiramatsu2
Khon Kaen University, Khon Kaen, Thailand
Graduate School of Medicine, Juntendo University, Tokyo, Japan
Faculty of Medicine, Khon Kaen University, Thailand;, Khon Kaen,
hailand
Veterinary Research and Development Center, Khon Kaen, Thailand
Background: Methicillin-resistant Staphylococcus aureus
MRSA) is mostly associated with hospital, whereas community-
cquired MRSA (CA-MRSA) infections in Thailand have been
ncommon. The present study aimed to investigate 14 MRSA
trains isolated from outpatients of a university hospital in
hailand.
Methods: Fourteen MRSA isolates were collected between
eptember 2005 and March 2006 from outpatients of a university
ospital inThailand. Minimum inhibitory concentrations (MICs) of
ix antimicrobial agents: vancomycin, cefazolin, oxacillin, cefoxitin,
etracycline, erythromycin and oﬂoxacin were determined using
n agar dilution method. Genotypic studies such as SCCmec type,
oagulase typ, agr type, spa type, multilocus sequence type (MLST)
ere performed using PCR and subsequent nucleotide sequences.
ulsed-ﬁeld gel electrophoresis (PFGE) of SmaI-digested chromo-
omal DNA was also performed.
Results: All 14 MRSA were multidrug-resistant with high MICs
f cefazolin, oxacillin, cefoxitin, tetracycline and erythromycin (32-
64g/ml), however all isolates were susceptible to vancomycin
MIC 1-2g/ml). Of the 14 isolates, 13 carried type III SCCmec
nd belonged to ST239, coagulase type IV, agr I and spa type-t037
ut one isolate was t233. The remaining isolate (strain JCSC6690)
arried a new SCCmec element, class C2 mec gene complex with
crA1B1, type XIc coagulase, agr II, spa type-t337 and ST9. PFGE of
he 14 isolates showed that 12 isolates gave similar bands pattern
o a hospital acquired-MRSA (HA-MRSA) from the same hospital.
he other isolates with spa type t337 and t233 showed a unique
NA proﬁle. The Panton-Valentine Leukocidin gene was not found
n these isolates. The strain JCSC6690 was isolated in March of
006, from a 2-year-old boy underlined with atopic dermatitis,
ttended the hospital because of suffering from chronic impetigo at
eft foot. The patient achieved good recovery after receiving cefa-
lor. He had never been admitted in a hospital during the former
ear. Nucleotide sequencing of the 57kb region at the downstream
f orfX revealed a novel SCCmec carrying type I ccr gene complex
nd classC2 mec gene complex.fectious Diseases 16S (2012) e158–e316
Conclusion: We reported a real community acquired-MRSA
(CA-MRSA) from a patient in Thailand with SCCmec type IX - ST9
which carried class C2 mec gene complex and ccrA1B1.
http://dx.doi.org/10.1016/j.ijid.2012.05.839
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Burkholderia cepacia and its secretory proteins
V. Mariappan1,∗, K.M. Vellasamy1, J. Thimma2, O. Hashim2, J.
Vadivelu3
1 University of Malaya, Kuala Lumour, Malaysia
2 University of Malaya, Kuala Lumpur, Malaysia
3 University Malaya, Kuala Lumpur, Malaysia
Background: Burkholderia cepacia causes serious respiratory
infections in immunocompromised individuals and patients with
cystic ﬁbrosis. The bacterium is known to produce virulence fac-
tors such as secretory enzymes which damage host membrane
to promote invasion as well as unique pilus which is involved in
adhesion and colonisation of the respiratory tract. Understanding
this complex cross-talk between the host and pathogen is essential
to improve understanding of an infectious disease and to identify
host-defense strategies including the underlying regulatory mech-
anisms. The aim of this study was to investigate the transcriptional
changes in thehostuponexposure to liveB. cepaciaand its secretory
proteins.
Methods: Comparison of host response to live B. cepacia (mid-
log phase) and its secretory proteins (mid-log and early stationary
phases) was performed using the Illumina HumanRef-8 microar-
ray platform. The raw microarray data were analyzed and the
web-based softwares GOTerm Finder (http://go.princeton.edu/cgi-
bin/GOTermFinder) and GeneTrail (http://genetrail.bioinf.uni-
sb.de/) were used to analyse signiﬁcant pathways. The microarray
data were validated using quantitative real-time polymerase chain
reaction.
Results: Interaction of the human epithelial cells, A549, with
live B. cepacia or the secretory proteins was found to differentially
regulate genes that are related to metabolism, cell cycle, apoptosis
and inﬂammatory. The host cell cycle andmetabolic pathways, par-
ticularly glycolysis/glycogenesis and fatty acid metabolism were
up-regulated transcriptionally. The host immune response was
also found to be manipulated through the suppression of pro-
inﬂammatory cytokines production. Additionally, the microarray
analysis indicated that the host cells inhibit the apoptotic path-
way during infection. Alteration of these pathways might explain
the need for the host cells to survive and proliferate to sustain cell
injuries caused by the secretory proteins and/or to allow prolonged
survival of B. cepacia in the host cells. These pathogens have also
been shown to modulate the epithelial bactericidal response in
favour of its intracellular survival and persistence in the human
host.Conclusion: The differential gene expression proﬁle of A549
cells towards B. cepacia infections has provided preliminary insight
into the mechanisms of pathogenesis of B. cepacia and its secre-
tory proteins. The microarray results permit a rational design for
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uture functional experiments to further characterise and elucidate
. cepacia infection.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.840
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tudy of detection Vibrio Cholerae O1 from Karoon river waters
nd their role in the public health
. Mehdinejad1,∗, N. NassirAbadi1, H. Godarzi2
Ahvaz Jundishapur University of Medical Sciences (AJUMS), Ahvaz,
ran, Islamic Republic of
Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran,
slamic Republic of
Background: Thewatershed of Dez andKaroon rivers located in
iddle Zagrous mountain with area about 68481-km, thus water-
hed is a part of Persian gulf watershed. Cholera, an acute intestinal
nfection caused by the bacterium Vibrio cholerae, is a historically
eared epidemic diarrheal disease that remains a major public
ealth problem in many parts of Africa, Asia, and Latin America.
ibrio cholerae O1 exists as two major serotypes, Inaba and Ogawa,
member of the family Vibrionaceae. Vibrio cholerae is transmit-
ed through freshwater contaminatedwith fecalmatter. Foodborne
nfections have been traced to rawor inadequately cooked shellﬁsh
nd other seafood. The target of study the segregate Vibrio cholerae
1 (Vibrionaceae) in the Karun Ahvaz river.
Methods: In four stages (April, May, June and July 2010), a total
00 samples ofwater fromKaroonRiverAhvazwere collected. Dur-
ng the study period the recorded river temperature was about
5-28(C and pH ranged from 7 to 8. Swabs were cultured onto
hiosulphate citrate bile sucrose and MacConkey, and morphologi-
al colonies compatible with Vibrio were characterized by oxidase
est and agglutinated with antiserum (Difco, Detroit, MI, USA) for
erotype determination. Also V. cholerae biochemical tests with API
0E (BioMerieux, Marcy-l’Etoile, France).
Results: From100 samples ofwater Karoon River in Ahvaz, Iran,
(8%) sample were positive for Vibrio cholerae strains. The isolated
trains fromwater KaroonRiver inAhvaz, Iran,wereVibrio cholerae
1 (inaba).
Conclusion: The priorities for cholera control remain pub-
ic health interventions through improved water and sanitation,
mproved surveillance and access to health care facilities, and fur-
her development of appropriate vaccines.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.841fectious Diseases 16S (2012) e158–e316 e231
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Safetyofpolymyxin-B-basedhemoperfusion inkidneyand liver
transplant recipients
V. Morabito ∗, G. Ferretti, F. Pugliese, S. Novelli, G. Novelli
Sapienza University, Rome, Italy
Background: Infection represents one of the primary barriers
to successful organ transplantation and an early diagnosis repre-
sent the goal of therapy. Our principal end point was to use a new
assay Test EAA which has been developed to rapidly detect endo-
toxin acivity. Furthermore we aim to prove the validity and safety
of removal of endotoxins using Polymyxin-B based hemoperfusion
(PMX-DHP).
Methods: The criteria for inclusion in the studywere the follow-
ing ﬁndings: infection was suspected when patients had at least
2 of the 4 criteria of systemic inﬂammatory response syndrome
(SIRS). Following these criteria, the Test EAA was performed on
71 patients (29 liver transplant and 42 kidney transplant). Twenty
eight patients(39,5%) with EA>0.60 were enrolled in this study
and received treatment to remove endotoxins (PMX-DHP). Each
treatment was performed for two hours with a blood ﬂow rate of
100mL/min. All the patients were treated with PMX-DHP until an
EA<0.4 was found.
Results: No relevant adverse events were observed during the
72 treatments performed.Before performing PMX-DHP treatments,
the median EA was 0.81(range 0.62-1.25) and 0.73(range 0.61-
0.98) in liver and kidney transplant patients respectively. In liver
transplant patients two PMX-DHP treatments were performed on
7 patients [median EA =0.69(0.62-0.76)], three treatments on 4
patients[median EA =0.84(0.77-0.91)] and four treatment on 3
patients [median EA =1.11(0.95-1.25)]. At the end of the endo-
toxin removal therapy, the median EA level was 0.33[0.22-0.4].The
stabilization of hemodynamic and inﬂammatory frameworks were
observed after the PMX-DHP.At 30 days of follow up all patients
were alive with a good graft function and low level of endotoxin
activity.
Conclusion: Given the progress achieved and considering the
particular difﬁculties in the diagnosis of transplant patients, we
think that might be useful to determine the endotoxin activity
routinely in these patients. Accordingly, larger multicenter clini-
cal trials will be necessary to accurately assess the beneﬁts of EA
essay plus DHP-PMX for transplant patients with endotoxemia and
suspect of infection.
http://dx.doi.org/10.1016/j.ijid.2012.05.842
